Thought Leadership

Regulatory Alert - Responding to Unsolicited Requests Via Social Media

This white paper highlights key points from the Food and Drug Administration's (FDA) first social media guidance, "Guidance to Industry: Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices."

Regulatory Alert - Responding to Unsolicited Requests Via Social Media





© 2017 Publicis Healthcare Communications Group. All rights reserved.